Susquehanna International Group’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.9M Buy
1,078,900
+395,800
+58% +$1.1M ﹤0.01% 5331
2025
Q4
$1.5M Buy
683,100
+266,000
+64% +$659K ﹤0.01% 6262
2025
Q3
$976K Buy
417,100
+167,100
+67% +$287K ﹤0.01% 7422
2025
Q2
$380K Buy
250,000
+136,700
+121% +$213K ﹤0.01% 9815
2025
Q1
$157K Sell
113,300
-4,200
-4% -$8.95K ﹤0.01% 11185
2024
Q4
$267K Buy
117,500
+30,400
+35% +$107K ﹤0.01% 10085
2024
Q3
$411K Buy
+87,100
New +$504K ﹤0.01% 8940
2024
Q2
Sell
-124,700
Closed -$2.13M 12097
2024
Q1
$2.13M Sell
124,700
-41,900
-25% -$899K ﹤0.01% 5196
2023
Q4
$3.78M Buy
166,600
+116,400
+232% +$1.96M ﹤0.01% 4196
2023
Q3
$764K Sell
50,200
-34,900
-41% -$477K ﹤0.01% 7248
2023
Q2
$1.1M Buy
85,100
+50,200
+144% +$545K ﹤0.01% 6460
2023
Q1
$289K Buy
34,900
+300
+0.9% +$2.81K ﹤0.01% 9808
2022
Q4
$320K Sell
34,600
-21,000
-38% -$76.5K ﹤0.01% 8933
2022
Q3
$36K Buy
+55,600
New +$66.9K ﹤0.01% 12377
2022
Q1
Sell
-29,600
Closed -$112K 13027
2021
Q4
$112K Sell
29,600
-29,400
-50% -$314K ﹤0.01% 12059
2021
Q3
$717K Buy
+59,000
New +$544K ﹤0.01% 8443

Other funds holding CABA

Susquehanna International Group's CABA Position: Q1 2026 in Review

Susquehanna International Group sold out of Cabaletta Bio (CABA) in Q1 2026, closing a stake of 138,281 shares — an estimated $384K sold.

Susquehanna International Group first reported a position in CABA in Q4 2019 and held it in 19 quarters. The position peaked at $2.19M in Q1 2023. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

  • Susquehanna International Group reported no remaining Cabaletta Bio position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 138,281 Cabaletta Bio shares in Q1 2026, an estimated $384K.
  • Susquehanna International Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 19 quarters.
  • Susquehanna International Group's Cabaletta Bio position peaked at $2.19M in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.